NASDAQ:LNSR

LENSAR (LNSR) Stock Price, News & Analysis

LENSAR logo
$4.50 -0.14 (-3.10%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$4.47 -0.03 (-0.67%)
As of 11/20/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About LENSAR Stock (NASDAQ:LNSR)

Advanced

Key Stats

Today's Range
$4.41
▼
$4.68
50-Day Range
$4.50
▼
$7.81
52-Week Range
$4.30
▼
$12.94
Volume
55,031 shs
Average Volume
69,610 shs
Market Capitalization
$55.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00
Consensus Rating
Hold

Company Overview

LENSAR, Inc. develops and markets laser-based technology for ophthalmic surgery, with a focus on procedures used to treat cataracts. Its systems are designed to assist surgeons with key steps in cataract surgery, including the creation of incisions and the fragmentation of the eye’s natural lens.

The company’s products include the ALLY Adaptive Cataract Treatment System and the LENSAR Laser System, which use imaging and software to support surgical planning and treatment. LENSAR also offers related software, accessories and services for ophthalmic practices and surgical facilities.

Based in Orlando, Florida, LENSAR serves eye surgeons and healthcare providers in the United States and international markets. The company was founded in 2004 and focuses on developing technology intended to support precision and workflow in cataract surgery.

AI Generated. May Contain Errors.

LENSAR Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
40th Percentile Overall Score

LNSR MarketRank™: 
2.01661315091 of 5 stars

LENSAR scored higher than 40% of companies evaluated by MarketBeat, and ranked 667th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    LENSAR has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    LENSAR has a consensus price target of $11.00, representing about 144.7% upside from its current price of $4.50.

  • Amount of Analyst Coverage

    LENSAR has only been the subject of 2 research reports in the past 90 days.

  • Read more about LENSAR's stock forecast and price target.
  • Price to Book Value per Share Ratio

    LENSAR has a P/B Ratio of 5.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    7.29% of the float of LENSAR has been sold short.
  • Short Interest Ratio / Days to Cover

    LENSAR has a short interest ratio ("days to cover") of 6.77.
  • Change versus previous month

    Short interest in LENSAR has recently decreased by 0.25%, indicating that investor sentiment is improving.
  • Dividend Yield

    LENSAR does not currently pay a dividend.

  • Dividend Growth

    LENSAR does not have a long track record of dividend growth.

  • News Sentiment

    LENSAR has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for LENSAR this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, LENSAR insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $169,989.00 in company stock.

  • Percentage Held by Insiders

    65.80% of the stock of LENSAR is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    40.15% of the stock of LENSAR is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about LENSAR's insider trading history.
Receive LNSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LENSAR and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

LNSR Stock News Headlines

Sanara MedTech (NASDAQ:SMTI) vs. LENSAR (NASDAQ:LNSR) Financial Survey
432 miles southeast of Washington, DC…
Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip maker for nearly four decades, including AMD, Intel, NVIDIA, Samsung and Taiwan Semiconductor. Washington is set to declare it a national strategic resource and ban its export. Apple, NVIDIA and Amazon have committed over $2 trillion, and Morgan Stanley estimates a $10 trillion economic boom. One small U.S. mining company sits at the center of it.tc pixel
Analyzing LENSAR (NASDAQ:LNSR) & Precision Optics (NASDAQ:POCI)
LENSAR (NASDAQ:LNSR) Rating Lowered to Sell at Wall Street Zen
Contrasting LENSAR (LNSR) and The Competition
See More Headlines

LNSR Stock Analysis - Frequently Asked Questions

LENSAR's stock was trading at $11.63 on January 1st, 2026. Since then, LNSR stock has decreased by 61.3% and is now trading at $4.4960.

LENSAR, Inc. (NASDAQ:LNSR) announced its earnings results on Tuesday, November, 10th. The company reported ($0.38) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by $0.29. The business had revenue of $14.13 million for the quarter, compared to analysts' expectations of $14.30 million. LENSAR had a net margin of 56.07% and a trailing twelve-month return on equity of 1,254.25%.
Read the conference call transcript
.

Top institutional investors of LENSAR include Marshall Wace LLP (1.50%), Mink Brook Asset Management LLC (0.81%), State Street Corp (0.59%) and Goldman Sachs Group Inc. (0.40%).
View institutional ownership trends
.

Shares of LNSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/10/2026
Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:LNSR
CIK
1320350
Fax
N/A
Employees
150
Year Founded
N/A

Price Target and Rating

High Price Target
$13.00
Low Price Target
$9.00
Potential Upside/Downside
+144.7%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.40)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$34.28 million
Net Margins
56.07%
Pretax Margin
56.07%
Return on Equity
1,254.25%
Return on Assets
49.13%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.25
Quick Ratio
0.98

Sales & Book Value

Annual Sales
$58.44 million
Price / Sales
0.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.90 per share
Price / Book
5.00

Miscellaneous

Outstanding Shares
12,290,000
Free Float
4,205,000
Market Cap
$55.26 million
Optionable
Optionable
Beta
1.03

Social Links

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (NASDAQ:LNSR) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners